Stock listing
Regeneron Pharmaceuticals, Inc.
- Ticker
- BIVA:REGN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BIVA
- Currency
- MXN
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a public company traded on the American stock market under the ticker REGN. Regeneron focuses on developing and commercializing innovative medicines for serious diseases.
Latest news from Regeneron Pharmaceuticals, Inc.
Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026
Oct 6, 2026
Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)
Oct 1, 2026
Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss
Oct 1, 2026
Upcoming Webinar Hosted by Xtalks: Inside Regeneron's Path to Scientific Intelligence and R&D Efficiency
Oct 1, 2026